Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

B John Moriarty


  • Evp, General Counsel at Portola Pharmaceuticals Inc (PTLA), 2020-02-05
  • Evp & General Counsel at Alexion Pharmaceuticals Inc (ALXN), 2018-02-09
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ALXN $115.70 1,200 Officer 74,537 2018-02-08 Filing
ALXN $115.70 2,163 Officer 75,737 2018-02-08 Filing
ALXN $117.26 1,261 Officer 49,911 2018-02-05 Filing
ALXN $132.50 282 Officer 44,672 2017-03-01 Filing
ALXN $131.71 910 Officer 44,954 2017-02-28 Filing